Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,792
Total Claims
$328K
Drug Cost
1,313
Beneficiaries
$250
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+24%
Opioid rate vs peers
51.2% vs 41.3% avg
-37%
Cost per patient vs peers
$250 vs $399 avg
+14%
Brand preference vs peers
4.3% vs 3.8% avg
Opioid Prescribing
51.2%
Opioid Rate
2,964
Opioid Claims
$141K
Opioid Cost
13.7%
Long-Acting Rate
This provider's opioid prescribing rate of 51.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 247 claims · $152K
Generic: 5,545 claims · $176K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Methylnaltrexone Bromide | 33 | $78K |
| Hydrocodone/Acetaminophen | 1,103 | $36K |
| Naloxone Hcl | 300 | $24K |
| Oxycodone Hcl/Acetaminophen | 486 | $21K |
| Oxycodone Hcl | 30 | $21K |
| Oxycodone Myristate | 32 | $15K |
| Oxycodone Hcl | 523 | $13K |
| Gabapentin | 577 | $11K |
| Naloxegol Oxalate | 22 | $9,966 |
| Buprenorphine | 23 | $9,206 |
| Pregabalin | 220 | $7,141 |
| Diclofenac Sodium | 226 | $6,502 |
| Morphine Sulfate | 241 | $6,194 |
| Lidocaine | 56 | $5,736 |
| Fentanyl | 43 | $5,031 |
Prescribing Profile
38
Unique Drugs
12.0
Anomaly Score
Patient Profile
69
Avg Age
58%
Female
1.69
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About